Ware RE - Search Results

1

Preservation of spleen and brain function in children with sickle cell anemia treated with hydroxyurea.

Hankins JS, Helton KJ, McCarville MB, Li CS, Wang WC, Ware RE. Hankins JS, et al. Among authors: ware re. Pediatr Blood Cancer. 2008 Feb;50(2):293-7. doi: 10.1002/pbc.21271. Pediatr Blood Cancer. 2008. PMID: 17554794

2

UGT1A promoter polymorphisms influence bilirubin response to hydroxyurea therapy in sickle cell anemia.

Heeney MM, Howard TA, Zimmerman SA, Ware RE. Heeney MM, et al. Among authors: ware re. J Lab Clin Med. 2003 Apr;141(4):279-82. doi: 10.1067/mlc.2003.28. J Lab Clin Med. 2003. PMID: 12677174 Clinical Trial.

3

Subclinical parvovirus B19 infection in children with sickle cell anemia.

Zimmerman SA, Davis JS, Schultz WH, Ware RE. Zimmerman SA, et al. Among authors: ware re. J Pediatr Hematol Oncol. 2003 May;25(5):387-9. doi: 10.1097/00043426-200305000-00007. J Pediatr Hematol Oncol. 2003. PMID: 12759625

4

Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease.

Zimmerman SA, Schultz WH, Davis JS, Pickens CV, Mortier NA, Howard TA, Ware RE. Zimmerman SA, et al. Among authors: ware re. Blood. 2004 Mar 15;103(6):2039-45. doi: 10.1182/blood-2003-07-2475. Epub 2003 Nov 20. Blood. 2004. PMID: 14630791 Free article. Clinical Trial.

5

Identification of hemochromatosis gene polymorphisms in chronically transfused patients with sickle cell disease.

Jeng MR, Adams-Graves P, Howard TA, Whorton MR, Li CS, Ware RE. Jeng MR, et al. Among authors: ware re. Am J Hematol. 2003 Dec;74(4):243-8. doi: 10.1002/ajh.10426. Am J Hematol. 2003. PMID: 14635204 Free article.

6

Chemical and functional analysis of hydroxyurea oral solutions.

Heeney MM, Whorton MR, Howard TA, Johnson CA, Ware RE. Heeney MM, et al. Among authors: ware re. J Pediatr Hematol Oncol. 2004 Mar;26(3):179-84. doi: 10.1097/00043426-200403000-00007. J Pediatr Hematol Oncol. 2004. PMID: 15125610

7

Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy.

Ware RE, Zimmerman SA, Sylvestre PB, Mortier NA, Davis JS, Treem WR, Schultz WH. Ware RE, et al. J Pediatr. 2004 Sep;145(3):346-52. doi: 10.1016/j.jpeds.2004.04.058. J Pediatr. 2004. PMID: 15343189

8

Enalapril and hydroxyurea therapy for children with sickle nephropathy.

Fitzhugh CD, Wigfall DR, Ware RE. Fitzhugh CD, et al. Among authors: ware re. Pediatr Blood Cancer. 2005 Dec;45(7):982-5. doi: 10.1002/pbc.20296. Pediatr Blood Cancer. 2005. PMID: 15704213

9

Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study.

Hankins JS, Ware RE, Rogers ZR, Wynn LW, Lane PA, Scott JP, Wang WC. Hankins JS, et al. Among authors: ware re. Blood. 2005 Oct 1;106(7):2269-75. doi: 10.1182/Blood-2004-12-4973. Blood. 2005. PMID: 16172253 Free PMC article. Clinical Trial.

10

Hemoglobinopathies mimicking Hb S/beta-thalassemia: Hb S/S with alpha-thalassemia and Hb S/Volga.

Luo HY, Heeney M, Wang WC, Eung SH, Ware RE, Steinberg MH, Chui DH. Luo HY, et al. Among authors: ware re. Am J Hematol. 2006 May;81(5):361-5. doi: 10.1002/ajh.20562. Am J Hematol. 2006. PMID: 16628724 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

377 results

Search Page

Filters